These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 781887)
1. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Cosimi AB; Wortis HH; Delmonico FL; Russell PS Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887 [TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H; Otte B; Lang D; Heidenreich S Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [TBL] [Abstract][Full Text] [Related]
4. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564 [TBL] [Abstract][Full Text] [Related]
5. Total and active T cell dynamics in renal allograft recipients. Kerman RH; Geis WP Surgery; 1976 Apr; 79(4):398-407. PubMed ID: 769220 [TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982 [TBL] [Abstract][Full Text] [Related]
7. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month. Daudu P; Wright K; Geelhoed GW Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286 [TBL] [Abstract][Full Text] [Related]
8. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
9. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480 [TBL] [Abstract][Full Text] [Related]
14. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat). Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731 [TBL] [Abstract][Full Text] [Related]
15. Effective monitoring and modulation of immune reactivity in allograft recipients. Thomas F; Lee HM; Thomas J; Mendez-Picon G Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063 [TBL] [Abstract][Full Text] [Related]
16. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients. Wang D; Wu WZ; Yang SL; Chen JH; Tan JM Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014 [TBL] [Abstract][Full Text] [Related]
17. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations. MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719 [TBL] [Abstract][Full Text] [Related]
18. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099 [TBL] [Abstract][Full Text] [Related]
19. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy. Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170 [TBL] [Abstract][Full Text] [Related]